Video Hero Poster

Beyond fulfilment

Contact Us

Boucher & Muir Pty Ltd (BNM), an ADVANZ PHARMA company, is an innovative pharmaceutical company delivering sustainable value across our product portfolio to customers in Australia, New Zealand and the South Pacific Islands.

BNM commenced business in 1957, a family owned and operated company. As an ADVANZ PHARMA company, BNM continues to espouse strong family values and, with its experienced and talented team, is committed to helping patients lead healthier, better lives by enabling patients and healthcare providers to access high-quality, niche, established medicines.

We do this by revitalising and innovating niche, established medicines that without our focus, may otherwise not be available to patients. Our customers, partners and patients value us because we go further than simply meeting their need for quality medicines and medical products. We believe in close, collaborative partnerships that build trust and inspire better solutions.

Latest News —

Image for ADVANZ PHARMA Releases Environmental, Social & Governance (ESG) Report for 2023-2024

Press Releases — 04 Oct 2024

ADVANZ PHARMA Releases Environmental, Social & Governance (ESG) Report for 2023-2024

Learn more
Image for ADVANZ PHARMA and Enzene Enter an Exclusive Partnership for Biosimilar Development and Commercialisation

Press Releases — 27 Aug 2024

ADVANZ PHARMA and Enzene Enter an Exclusive Partnership for Biosimilar Development and Commercialisation

Learn more
Image for European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Press Releases — 15 Aug 2024

European Medicines Agency Confirms Acceptance of Marketing Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Learn more
Image for Alvotech and ADVANZ PHARMA Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe

Press Releases — 18 Jun 2024

Alvotech and ADVANZ PHARMA Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe

Learn more
Image for ADVANZ PHARMA and Allecra Therapeutics announce approval in the European Union for the new antibiotic combination EXBLIFEP® (cefepime/enmetazobactam) for the treatment of severe infections

Press Releases — 27 Mar 2024

ADVANZ PHARMA and Allecra Therapeutics announce approval in the European Union for the new antibiotic combination EXBLIFEP® (cefepime/enmetazobactam) for the treatment of severe infections

Learn more
Image for ADVANZ PHARMA receives positive CHMP opinion for EXBLIFEP® (cefepime/enmetazobactam)

Press Releases — 26 Jan 2024

ADVANZ PHARMA receives positive CHMP opinion for EXBLIFEP® (cefepime/enmetazobactam)

Learn more

Our Portfolio —

Our portfolio consists of Amdipharm, Mercury and BNM Group Products in both Australia and New Zealand

All products under the Amdipharm and Mercury banner are owned by ADVANZ PHARMA with the majority of the BNM Group products both in Australia and New Zealand being in licensed.

Careers & Culture —

We like to think we’re a breath of fresh air. We’re a business that’s not afraid to evolve. To rethink the way we work. To strive for more. In fact, our forward-thinking approach is one of the reasons we branded last year.

Responsibility —

ADVANZ PHARMA takes its Environmental, Social & Governance (ESG) responsibilities very seriously. We have been sponsoring a number of charities for many years and have an active environmental programme.

Our Partnerships —

ADVANZ PHARMA has a long history of collaboration whether it is working with licensing opportunities, acquiring new products or distribution logistics, we work with a multitude of partners across the world.

About Us —

Boucher & Muir Pty Ltd (BNM), an ADVANZ PHARMA company, is an innovative pharmaceutical company delivering sustainable value across our product portfolio to customers…

BNM commenced business in 1957, a family owned and operated company. As an ADVANZ PHARMA company, BNM continues to espouse strong family values and, with its experienced and talented team, strives to go beyond the fulfilment of orders for medicines and medical products, to be a trusted and respected partner in protecting the health of families.

Subscribe for the latest press releases delivered to your inbox

Please select all the ways you would like to hear from ADVANZ PHARMA:

You can unsubscribe at any time by clicking the link in the footer of our emails.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.